ORI Updates

ORI found that Dr. Kadam engaged in research misconduct in research supported by National Eye Institute (NEI), National Institutes of Health (NIH).

Dr. Rakesh Srivastava engaged in research misconduct in research proposed or reported in grant application in research supported by PHS grants.  Dr. Rakesh Srivastava requested a hearing before an Administrative Law Judge (ALJ) of the Departmental Appeals Board to dispute the findings. The ALJ issued a recommended decision to the Assistant Secretary for Health (ASH) granting summary judgment in favor of ORI and to impose a two-year debarment and a two-year ban...

NIH has issued a policy explaining when NIH has a need to know about matters related to research misconduct proceedings.

Join Vanderbilt University for the 3rd Annual GRIT Conference.

The Office of Research Integrity (ORI) has named Brian Mozer, PhD, to serve as the Acting Director of the Division of Investigative Oversight (DIO) on a 120-day detail appointment.

Learn how you can communicate more effectively in your laboratory.

ORI has developed a series of infographics addressing the Responsible Conduct of Research and the handling of research misconduct.

GS-15 Supervisory Health Scientist for the Division of Investigative Oversight will be removed for correction of technical errors and will be reposted as soon as possible.

OHRP has several useful educational resources for RCR professionals.

ORI found that Dr. Wang engaged in research misconduct by recklessly including false data in National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH).